Oxford Drug Design is a seed startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Oxford Drug Design is a structure-based drug design company with a focus on early-stage drug discovery. It offers services such as protein structure determination, fragment screening, and computational chemistry to accelerate the drug discovery process.
Stage
seed
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky